Long-term immune persistence induced by two-dose BBIBP-CorV vaccine with different intervals, and immunogenicity and safety of a homologous booster dose in high-risk occupational population Secondary Study Based on a Randomized Clinical Trial

Tian Yao, Xiaohong Zhang, Shengcai Mu, Yana Guo, Xiuyang Xu, Junfeng Huo, Zhiyun Wei, Ling Liu, Xiaoqing Li, Hong Li, Rongqin Xing, Yongliang Feng, Jing Chen, Lizhong Feng, Suping Wang
doi: https://doi.org/10.1101/2022.06.22.22276690

Article usage

Article usage: June 2022 to May 2025

AbstractFullPdf
Jun 20224371087
Jul 2022222253
Aug 202279111
Sep 20227717
Oct 202271010
Nov 202248011
Dec 202257011
Jan 20232505
Feb 20232237
Mar 20233004
Apr 202321111
May 20231528
Jun 20231042
Jul 2023714
Aug 20231793
Sep 20231248
Oct 20231331
Nov 202328185
Dec 202314110
Jan 20241223
Feb 2024842
Mar 20241737
Apr 2024101512
May 2024843
Jun 202428814
Jul 202414615
Aug 202418512
Sep 20241954
Oct 20241124
Nov 2024928
Dec 20241013
Jan 202518212
Feb 202514276
Mar 2025292719
Apr 202527112
May 2025722
Back to top
Posted June 26, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Long-term immune persistence induced by two-dose BBIBP-CorV vaccine with different intervals, and immunogenicity and safety of a homologous booster dose in high-risk occupational population Secondary Study Based on a Randomized Clinical Trial
Tian Yao, Xiaohong Zhang, Shengcai Mu, Yana Guo, Xiuyang Xu, Junfeng Huo, Zhiyun Wei, Ling Liu, Xiaoqing Li, Hong Li, Rongqin Xing, Yongliang Feng, Jing Chen, Lizhong Feng, Suping Wang
medRxiv 2022.06.22.22276690; doi: https://doi.org/10.1101/2022.06.22.22276690
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area